Influenza Vaccines Market & Forecast - Worldwide Analysis
Influenza Vaccines Market Analysis
The Influenza vaccines market represent an attractive market characterize by sturdy growth prospects. Increasing awareness, growing vaccination coverage in the emerging countries, rising government support for immunization against Seasonal Influenza and increased focus on the production of treatments for vulnerable populations by introducing new vaccines and vaccines with a better route of administration are the main drivers to galvanized Influenza vaccines market.
Seasonal Influenza vaccines market has Billions US$ market in 2013. Seasonal Influenza vaccines market is expected to grow with double digit percentage from 2013 to 2019. On the other hand, H1N1 Influenza vaccines market has seen tremendous growth during 2009 and 2010 primarily driven by the global spread of H1N1 Influenza virus. However, strong demand of Influenza vaccines contracted in 2011 by more than 50% due to waning threat of swine flu epidemic.
United States remains the largest market for Seasonal Influenza vaccines. Japan and emerging countries like China, India and Brazil is likely to drive Influenza vaccines markets in the next 5 to 6 years. Netherlands and United Kingdom have achieved greater vaccinations coverage.
In the major Seasonal Influenza vaccines sales segment, Fluzone (Sanofi Pasteur) has the highest sales figures and likely to maintain leadership position in the Seasonal Influenza vaccines market.
This is 2nd edition report on Influenza Vaccines by Renub Research. Research study titled “Influenza Vaccines Market & Forecast - Worldwide Analysis” provides a comprehensive assessment of the fast-evolving, high-growth of World Influenza Vaccines landscape. This 179 page report with 140 Figures and 7 Tables examines the following segments for Influenza Vaccines Market
1. United States
2. Japan
3. China
4. India
5. Brazil
6. Netherlands
7. Germany
8. France
9. Italy
10. Spain
11. Denmark
12. Sweden
13. Portugal
14. Luxembourg
15. Lithuania
16. United Kingdom
17. Poland
18. Norway
19. Romania
20. Estonia
21. Finland
22. Hungary
23. Ireland
24. Iceland
25. Latvia
26. Malta
27. Slovakia
28. Slovenia
29. Australia
30. New Zealand
Top 6 Seasonal Influenza Vaccines Sales Performance Studied in the Report are as Follows
1. Fluarix / Flulaval
2. Afluria/Fluvax
3. FluMist/Fluenz
4. Influvac
5. Fluvirin / Flucelvax
6. Fluzone
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
The Influenza vaccines market represent an attractive market characterize by sturdy growth prospects. Increasing awareness, growing vaccination coverage in the emerging countries, rising government support for immunization against Seasonal Influenza and increased focus on the production of treatments for vulnerable populations by introducing new vaccines and vaccines with a better route of administration are the main drivers to galvanized Influenza vaccines market.
Seasonal Influenza vaccines market has Billions US$ market in 2013. Seasonal Influenza vaccines market is expected to grow with double digit percentage from 2013 to 2019. On the other hand, H1N1 Influenza vaccines market has seen tremendous growth during 2009 and 2010 primarily driven by the global spread of H1N1 Influenza virus. However, strong demand of Influenza vaccines contracted in 2011 by more than 50% due to waning threat of swine flu epidemic.
United States remains the largest market for Seasonal Influenza vaccines. Japan and emerging countries like China, India and Brazil is likely to drive Influenza vaccines markets in the next 5 to 6 years. Netherlands and United Kingdom have achieved greater vaccinations coverage.
In the major Seasonal Influenza vaccines sales segment, Fluzone (Sanofi Pasteur) has the highest sales figures and likely to maintain leadership position in the Seasonal Influenza vaccines market.
This is 2nd edition report on Influenza Vaccines by Renub Research. Research study titled “Influenza Vaccines Market & Forecast - Worldwide Analysis” provides a comprehensive assessment of the fast-evolving, high-growth of World Influenza Vaccines landscape. This 179 page report with 140 Figures and 7 Tables examines the following segments for Influenza Vaccines Market
- Worldwide Influenza vaccines market (2009 - 2019)
- Worldwide Seasonal Influenza vaccines market has been covered from (2009 – 2019)
- Worldwide Swine Flu (H1N1) Influenza vaccines market has been covered from (2009 – 2011)
- Worldwide number of persons being vaccinated with Seasonal Influenza vaccines (2009 - 2019)
- Top 30 countries number of persons being vaccinated with Seasonal Influenza vaccines (2009 - 2019)
- Top 30 countries Seasonal Influenza vaccines market (2008 – 2019)
- Top Brands Seasonal Influenza vaccines (Fluarix/Flulaval, Afluria/Fluvax, FluMist/Fluenz, Influvac, Fluvirin / Flucelvax, Fluzone) Sales Performance & Forecast
- Top Merger & Acquisition deals in Influenza Vaccines Market
- Key drivers of growth in the Worldwide Influenza Vaccines Market
- Key challenges faces by Influenza Vaccines Market
1. United States
2. Japan
3. China
4. India
5. Brazil
6. Netherlands
7. Germany
8. France
9. Italy
10. Spain
11. Denmark
12. Sweden
13. Portugal
14. Luxembourg
15. Lithuania
16. United Kingdom
17. Poland
18. Norway
19. Romania
20. Estonia
21. Finland
22. Hungary
23. Ireland
24. Iceland
25. Latvia
26. Malta
27. Slovakia
28. Slovenia
29. Australia
30. New Zealand
Top 6 Seasonal Influenza Vaccines Sales Performance Studied in the Report are as Follows
1. Fluarix / Flulaval
2. Afluria/Fluvax
3. FluMist/Fluenz
4. Influvac
5. Fluvirin / Flucelvax
6. Fluzone
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
1. EXECUTIVE SUMMARY
2. WORLDWIDE INFLUENZA VACCINES MARKET & FORECAST
2.1 Worldwide – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
2.2 Merger and Acquisition in Influenza Vaccines Market
3. WORLDWIDE – SEASONAL INFLUENZA VACCINES MARKET & FORECAST
4. WORLDWIDE – SWINE FLU (H1N1) INFLUENZA VACCINES MARKET
5. WORLDWIDE INFLUENZA VACCINES MARKET SHARE & FORECAST
5.1 Segment wise – Influenza Vaccines Market Share & Forecast
5.2 Countries wise – Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines Share & Forecast
5.3 Countries wise – Seasonal Influenza Vaccines Market Share & Forecast
6. GEOGRAPHICAL SEGMENTATION – SEASONAL INFLUENZA VACCINES MARKET & VACCINATION COVERAGE (2008 – 2019)
6.1 United States
6.1.1 United States – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.1.2 United States – Seasonal Influenza Vaccines Market & Forecast
6.2 Japan
6.2.1 Japan – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.2.2 Japan – Seasonal Influenza Vaccines Market & Forecast
6.3 China
6.3.1 China – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.3.2 China – Seasonal Influenza Vaccines Market & Forecast
6.4 India
6.4.1 India – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.4.2 India – Seasonal Influenza Vaccines Market & Forecast
6.5 Brazil
6.5.1 Brazil – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.5.2 Brazil – Seasonal Influenza Vaccines Market & Forecast
6.6 Netherlands
6.6.1 Netherlands – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.6.2 Netherlands – Seasonal Influenza Vaccines Market & Forecast
6.7 Germany
6.7.1 Germany – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.7.2 Germany – Seasonal Influenza Vaccines Market & Forecast
6.8 France
6.8.1 France – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.8.2 France – Seasonal Influenza Vaccines Market & Forecast
6.9 Italy
6.9.1 Italy – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.9.2 Italy – Seasonal Influenza Vaccines Market & Forecast
6.10 Spain
6.10.1 Spain – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.10.2 Spain – Seasonal Influenza Vaccines Market & Forecast
6.11 Denmark
6.11.1 Denmark – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.11.2 Denmark – Seasonal Influenza Vaccines Market & Forecast
6.12 Sweden
6.12.1 Sweden – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.12.2 Sweden – Seasonal Influenza Vaccines Market & Forecast
6.13 Portugal
6.13.1 Portugal – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.13.2 Portugal – Seasonal Influenza Vaccines Market & Forecast
6.14 Luxembourg
6.14.1 Luxembourg – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.14.2 Luxembourg – Seasonal Influenza Vaccines Market & Forecast
6.15 Lithuania
6.15.1 Lithuania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.15.2 Lithuania – Seasonal Influenza Vaccines Market & Forecast
6.16 United Kingdom
6.16.1 United Kingdom – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.16.2 United Kingdom – Seasonal Influenza Vaccines Market & Forecast
6.17 Poland
6.17.1 Poland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.17.2 Poland – Seasonal Influenza Vaccines Market & Forecast
6.18 Norway
6.18.1 Norway – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.18.2 Norway – Seasonal Influenza Vaccines Market & Forecast
6.19 Romania
6.19.1 Romania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.19.2 Romania – Seasonal Influenza Vaccines Market & Forecast
6.20 Estonia
6.20.1 Estonia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.20.2 Estonia – Seasonal Influenza Vaccines Market & Forecast
6.21 Finland
6.21.1 Finland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.21.2 Finland – Seasonal Influenza Vaccines Market & Forecast
6.22 Hungary
6.22.1 Hungary – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.22.2 Hungary – Seasonal Influenza Vaccines Market & Forecast
6.23 Ireland
6.23.1 Ireland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.23.2 Ireland – Seasonal Influenza Vaccines Market & Forecast
6.24 Iceland
6.24.1 Iceland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.24.2 Iceland – Seasonal Influenza Vaccines Market & Forecast
6.25 Latvia
6.25.1 Latvia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.25.2 Latvia – Seasonal Influenza Vaccines Market & Forecast
6.26 Malta
6.26.1 Malta – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.26.2 Malta – Seasonal Influenza Vaccines Market & Forecast
6.27 Slovakia
6.27.1 Slovakia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.27.2 Slovakia – Seasonal Influenza Vaccines Market & Forecast
6.28 Slovenia
6.28.1 Slovenia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.28.2 Slovenia – Seasonal Influenza Vaccines Market & Forecast
6.29 Australia
6.29.1 Australia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.29.2 Australia – Seasonal Influenza Vaccines Market & Forecast
6.30 New Zealand
6.30.1 New Zealand – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.30.2 New Zealand – Seasonal Influenza Vaccines Market & Forecast
7. WORLDWIDE – SEASONAL INFLUENZA VACCINE BRAND SALES & FORECAST
7.1 Fluarix / Flulaval – Sales Performance & Forecast
7.2 Afluria/Fluvax – Sales Performance & Forecast
7.3 FluMist/Fluenz – Sales Performance & Forecast
7.4 Influvac (Now Acquired by Abbott) – Sales Performance & Forecast
7.5 Fluvirin / Flucelvax – Sales Performance & Forecast
7.6 Fluzone – Sales Performance & Forecast
8. GROWTH DRIVERS IN THE INFLUENZA VACCINES MARKET
8.1 Transforming Vaccine Technologies
8.2 Continuous Focus on Effective Communication Strategies
8.3 Vaccines most Cost Effective Means of Disease Prevention
8.4 Scientific & Technological Breakthroughs
8.5 Promote Education, Training, & Information exchange on Seasonal Influenza & Vaccination in European Countries
9. CHALLENGES FOR INFLUENZA VACCINE MARKET
9.1 Obstacle to Best Possible use of Licensed Vaccines
9.1.1 Economic Obstacles
9.1.2 Technical Obstacles
9.1.3 Cultural Obstacles
9.2 Difficulty of Influenza Vaccine Development & Approval System
9.2.1 General Technical Barriers
9.2.2 Economic Barriers
9.2.3 Legal Barriers
9.2.4 Regulatory Barriers
9.3 Reducing the Timeline for Vaccine Development
9.4 Problem Faced by Healthcare Workers in Immunization
2. WORLDWIDE INFLUENZA VACCINES MARKET & FORECAST
2.1 Worldwide – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
2.2 Merger and Acquisition in Influenza Vaccines Market
3. WORLDWIDE – SEASONAL INFLUENZA VACCINES MARKET & FORECAST
4. WORLDWIDE – SWINE FLU (H1N1) INFLUENZA VACCINES MARKET
5. WORLDWIDE INFLUENZA VACCINES MARKET SHARE & FORECAST
5.1 Segment wise – Influenza Vaccines Market Share & Forecast
5.2 Countries wise – Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines Share & Forecast
5.3 Countries wise – Seasonal Influenza Vaccines Market Share & Forecast
6. GEOGRAPHICAL SEGMENTATION – SEASONAL INFLUENZA VACCINES MARKET & VACCINATION COVERAGE (2008 – 2019)
6.1 United States
6.1.1 United States – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.1.2 United States – Seasonal Influenza Vaccines Market & Forecast
6.2 Japan
6.2.1 Japan – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.2.2 Japan – Seasonal Influenza Vaccines Market & Forecast
6.3 China
6.3.1 China – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.3.2 China – Seasonal Influenza Vaccines Market & Forecast
6.4 India
6.4.1 India – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.4.2 India – Seasonal Influenza Vaccines Market & Forecast
6.5 Brazil
6.5.1 Brazil – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.5.2 Brazil – Seasonal Influenza Vaccines Market & Forecast
6.6 Netherlands
6.6.1 Netherlands – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.6.2 Netherlands – Seasonal Influenza Vaccines Market & Forecast
6.7 Germany
6.7.1 Germany – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.7.2 Germany – Seasonal Influenza Vaccines Market & Forecast
6.8 France
6.8.1 France – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.8.2 France – Seasonal Influenza Vaccines Market & Forecast
6.9 Italy
6.9.1 Italy – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.9.2 Italy – Seasonal Influenza Vaccines Market & Forecast
6.10 Spain
6.10.1 Spain – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.10.2 Spain – Seasonal Influenza Vaccines Market & Forecast
6.11 Denmark
6.11.1 Denmark – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.11.2 Denmark – Seasonal Influenza Vaccines Market & Forecast
6.12 Sweden
6.12.1 Sweden – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.12.2 Sweden – Seasonal Influenza Vaccines Market & Forecast
6.13 Portugal
6.13.1 Portugal – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.13.2 Portugal – Seasonal Influenza Vaccines Market & Forecast
6.14 Luxembourg
6.14.1 Luxembourg – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.14.2 Luxembourg – Seasonal Influenza Vaccines Market & Forecast
6.15 Lithuania
6.15.1 Lithuania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.15.2 Lithuania – Seasonal Influenza Vaccines Market & Forecast
6.16 United Kingdom
6.16.1 United Kingdom – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.16.2 United Kingdom – Seasonal Influenza Vaccines Market & Forecast
6.17 Poland
6.17.1 Poland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.17.2 Poland – Seasonal Influenza Vaccines Market & Forecast
6.18 Norway
6.18.1 Norway – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.18.2 Norway – Seasonal Influenza Vaccines Market & Forecast
6.19 Romania
6.19.1 Romania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.19.2 Romania – Seasonal Influenza Vaccines Market & Forecast
6.20 Estonia
6.20.1 Estonia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.20.2 Estonia – Seasonal Influenza Vaccines Market & Forecast
6.21 Finland
6.21.1 Finland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.21.2 Finland – Seasonal Influenza Vaccines Market & Forecast
6.22 Hungary
6.22.1 Hungary – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.22.2 Hungary – Seasonal Influenza Vaccines Market & Forecast
6.23 Ireland
6.23.1 Ireland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.23.2 Ireland – Seasonal Influenza Vaccines Market & Forecast
6.24 Iceland
6.24.1 Iceland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.24.2 Iceland – Seasonal Influenza Vaccines Market & Forecast
6.25 Latvia
6.25.1 Latvia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.25.2 Latvia – Seasonal Influenza Vaccines Market & Forecast
6.26 Malta
6.26.1 Malta – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.26.2 Malta – Seasonal Influenza Vaccines Market & Forecast
6.27 Slovakia
6.27.1 Slovakia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.27.2 Slovakia – Seasonal Influenza Vaccines Market & Forecast
6.28 Slovenia
6.28.1 Slovenia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.28.2 Slovenia – Seasonal Influenza Vaccines Market & Forecast
6.29 Australia
6.29.1 Australia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.29.2 Australia – Seasonal Influenza Vaccines Market & Forecast
6.30 New Zealand
6.30.1 New Zealand – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
6.30.2 New Zealand – Seasonal Influenza Vaccines Market & Forecast
7. WORLDWIDE – SEASONAL INFLUENZA VACCINE BRAND SALES & FORECAST
7.1 Fluarix / Flulaval – Sales Performance & Forecast
7.2 Afluria/Fluvax – Sales Performance & Forecast
7.3 FluMist/Fluenz – Sales Performance & Forecast
7.4 Influvac (Now Acquired by Abbott) – Sales Performance & Forecast
7.5 Fluvirin / Flucelvax – Sales Performance & Forecast
7.6 Fluzone – Sales Performance & Forecast
8. GROWTH DRIVERS IN THE INFLUENZA VACCINES MARKET
8.1 Transforming Vaccine Technologies
8.2 Continuous Focus on Effective Communication Strategies
8.3 Vaccines most Cost Effective Means of Disease Prevention
8.4 Scientific & Technological Breakthroughs
8.5 Promote Education, Training, & Information exchange on Seasonal Influenza & Vaccination in European Countries
9. CHALLENGES FOR INFLUENZA VACCINE MARKET
9.1 Obstacle to Best Possible use of Licensed Vaccines
9.1.1 Economic Obstacles
9.1.2 Technical Obstacles
9.1.3 Cultural Obstacles
9.2 Difficulty of Influenza Vaccine Development & Approval System
9.2.1 General Technical Barriers
9.2.2 Economic Barriers
9.2.3 Legal Barriers
9.2.4 Regulatory Barriers
9.3 Reducing the Timeline for Vaccine Development
9.4 Problem Faced by Healthcare Workers in Immunization
LIST OF TABLES
Table 2 1: Worldwide – Merger and Acquisition in Influenza Vaccines Market (Million US$), 2005 – 2011
Table 5 1: Countries wise – Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines Share (Percent), 2009 – 2013
Table 5 2: Countries wise – Forecast for Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines Share (Percent), 2014 – 2019
Table 5 3: Countries wise – Seasonal Influenza Vaccines Market Share (Percent), 2009 – 2013
Table 5 4: Countries wise – Forecast for Seasonal Influenza Vaccines Market Share (Percent), 2014 – 2019
Table 8 1: Improvement Strategies or Requirements – the Joint Commission and the Project’s Collaborating Organizations
Table 8 2: Initiatives Taken in Communication, Education, Training & Information Exchange Related to Seasonal Influenza in European Countries, 2009
Table 2 1: Worldwide – Merger and Acquisition in Influenza Vaccines Market (Million US$), 2005 – 2011
Table 5 1: Countries wise – Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines Share (Percent), 2009 – 2013
Table 5 2: Countries wise – Forecast for Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines Share (Percent), 2014 – 2019
Table 5 3: Countries wise – Seasonal Influenza Vaccines Market Share (Percent), 2009 – 2013
Table 5 4: Countries wise – Forecast for Seasonal Influenza Vaccines Market Share (Percent), 2014 – 2019
Table 8 1: Improvement Strategies or Requirements – the Joint Commission and the Project’s Collaborating Organizations
Table 8 2: Initiatives Taken in Communication, Education, Training & Information Exchange Related to Seasonal Influenza in European Countries, 2009
LIST OF FIGURES
Figure 2 1: Worldwide – Influenza Vaccines Market (Million US$), 2009 – 2013
Figure 2 2: Worldwide – Forecast for Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 2 3: Worldwide – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Million), 2009 – 2013
Figure 2 4: Worldwide – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Million), 2014 – 2019
Figure 3 1: Worldwide – Seasonal Influenza Vaccines Market (Million US$), 2009 – 2013
Figure 3 2: Worldwide – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 4 1: Worldwide – Swine Flu (H1N1) Influenza Vaccines Market (Million US$), 2009 – 2011
Figure 5 1: Segment wise – Influenza Vaccines Market Share (Percent), 2009 – 2013
Figure 5 2: Segment wise – Forecast for Influenza Vaccines Market Share (Percent), 2014 – 2019
Figure 6 1: United States – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2009 – 2013
Figure 6 2: United States – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 3: United States – Seasonal Influenza Vaccines Market (Million US$), 2009 – 2013
Figure 6 4: United States – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 5: Japan – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 6: Japan – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 7: Japan – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 8: Japan – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 9: China – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008–2013
Figure 6 10: China – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 11: China – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 12: China – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 13: India – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 14: India – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 15: India – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 16: India – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 17: Brazil – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 18: Brazil – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 19: Brazil – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 20: Brazil – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 21: Netherlands – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 22: Netherlands – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 23: Netherlands – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 24: Netherlands – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 25: Germany – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 26: Germany – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 27: Germany – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 28: Germany – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 29: France – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 30: France – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 31: France – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 32: France – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 33: Italy – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 34: Italy – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 35: Italy – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 36: Italy – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 37: Spain – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 38: Spain – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 39: Spain – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 40: Spain – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 41: Denmark – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 42: Denmark – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 43: Denmark – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 44: Denmark – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 45: Sweden – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 46: Sweden – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 47: Sweden – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 48: Sweden – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 49: Portugal – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 50: Portugal – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 51: Portugal – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 52: Portugal – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 53: Luxembourg – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 54: Luxembourg – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 55: Luxembourg – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 56: Luxembourg – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 57: Lithuania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 58: Lithuania – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 59: Lithuania – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 60: Lithuania – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 61: United Kingdom – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 62: United Kingdom – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 63: United Kingdom – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 64: United Kingdom – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 65: Poland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 66: Poland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 67: Poland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 68: Poland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 69: Norway – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 70: Norway – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 71: Norway – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 72: Norway – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 73: Romania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 74: Romania – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 75: Romania – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 76: Romania – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 77: Estonia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 78: Estonia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 79: Estonia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 80: Estonia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 81: Finland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 82: Finland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 83: Finland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 84: Finland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 85: Hungary – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 86: Hungary – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 87: Hungary – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 88: Hungary – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 89: Ireland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008–2013
Figure 6 90: Ireland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 91: Ireland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 92: Ireland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 93: Iceland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 94: Iceland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 95: Iceland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 96: Iceland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 97: Latvia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 98: Latvia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 99: Latvia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 100: Latvia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 101: Malta – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 102: Malta – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 103: Malta – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 104: Malta – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 105: Slovakia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 106: Slovakia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 107: Slovakia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 108: Slovakia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 109: Slovenia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 110: Slovenia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 111: Slovenia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 112: Slovenia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 113: Australia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 114: Australia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 115: Australia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 116: Australia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 117: New Zealand – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 118: New Zealand – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 119: New Zealand – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 120: New Zealand – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 7 1: Worldwide – Fluarix / Flulaval Seasonal Influenza Vaccine Sales (Million US$), 2007 – 2013
Figure 7 2: Worldwide – Forecast for Fluarix / Flulaval Seasonal Influenza Vaccine Sales (Million US$), 2014 – 2019
Figure 7 3: Worldwide – Afluria/Fluvax Seasonal Influenza Vaccine Sales (Million US$), 2010 – 2013
Figure 7 4: Worldwide – Forecast for Afluria/Fluvax Seasonal Influenza Vaccine Sales (Million US$), 2014 – 2019
Figure 7 5: Worldwide – Flumist/ Fluenz Seasonal Infuenza Vaccine Sales (Million US$), 2009 – 2013
Figure 7 6: Worldwide – Forecast for Flumist/Fluenz Seasonal Influenza Vaccine Sales (Million US$), 2014 – 2019
Figure 7 7: Worldwide – Influvac Seasonal Infuenza Vaccine Sales (Million US$), 2007 – 2009
Figure 7 8: Worldwide – Fluvirin/Flucelvax Seasonal Infuenza Vaccine Sales (Million US$), 2010 – 2013
Figure 7 9: Worldwide – Forecast for Fluvirin/Flucelvax Seasonal Infuenza Vaccine Sales (Million US$), 2014 – 2019
Figure 7 10: Worldwide – Fluzone Seasonal Infuenza Vaccine Sales (Million US$), 2009 – 2013
Figure 7 11: Worldwide – Forecast for Fluzone Seasonal Infuenza Vaccine Sales (Million US$), 2014 – 2019
Figure 2 1: Worldwide – Influenza Vaccines Market (Million US$), 2009 – 2013
Figure 2 2: Worldwide – Forecast for Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 2 3: Worldwide – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Million), 2009 – 2013
Figure 2 4: Worldwide – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Million), 2014 – 2019
Figure 3 1: Worldwide – Seasonal Influenza Vaccines Market (Million US$), 2009 – 2013
Figure 3 2: Worldwide – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 4 1: Worldwide – Swine Flu (H1N1) Influenza Vaccines Market (Million US$), 2009 – 2011
Figure 5 1: Segment wise – Influenza Vaccines Market Share (Percent), 2009 – 2013
Figure 5 2: Segment wise – Forecast for Influenza Vaccines Market Share (Percent), 2014 – 2019
Figure 6 1: United States – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2009 – 2013
Figure 6 2: United States – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 3: United States – Seasonal Influenza Vaccines Market (Million US$), 2009 – 2013
Figure 6 4: United States – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 5: Japan – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 6: Japan – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 7: Japan – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 8: Japan – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 9: China – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008–2013
Figure 6 10: China – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 11: China – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 12: China – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 13: India – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 14: India – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 15: India – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 16: India – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 17: Brazil – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 18: Brazil – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 19: Brazil – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 20: Brazil – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 21: Netherlands – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 22: Netherlands – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 23: Netherlands – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 24: Netherlands – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 25: Germany – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 26: Germany – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 27: Germany – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 28: Germany – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 29: France – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 30: France – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 31: France – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 32: France – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 33: Italy – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 34: Italy – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 35: Italy – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 36: Italy – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 37: Spain – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 38: Spain – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 39: Spain – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 40: Spain – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 41: Denmark – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 42: Denmark – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 43: Denmark – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 44: Denmark – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 45: Sweden – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 46: Sweden – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 47: Sweden – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 48: Sweden – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 49: Portugal – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 50: Portugal – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 51: Portugal – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 52: Portugal – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 53: Luxembourg – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 54: Luxembourg – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 55: Luxembourg – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 56: Luxembourg – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 57: Lithuania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 58: Lithuania – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 59: Lithuania – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 60: Lithuania – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 61: United Kingdom – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 62: United Kingdom – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 63: United Kingdom – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 64: United Kingdom – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 65: Poland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 66: Poland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 67: Poland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 68: Poland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 69: Norway – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 70: Norway – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 71: Norway – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 72: Norway – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 73: Romania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 74: Romania – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 75: Romania – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 76: Romania – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 77: Estonia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 78: Estonia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 79: Estonia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 80: Estonia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 81: Finland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 82: Finland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 83: Finland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 84: Finland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 85: Hungary – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 86: Hungary – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 87: Hungary – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 88: Hungary – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 89: Ireland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008–2013
Figure 6 90: Ireland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 91: Ireland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 92: Ireland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 93: Iceland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 94: Iceland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 95: Iceland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 96: Iceland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 97: Latvia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 98: Latvia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 99: Latvia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 100: Latvia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 101: Malta – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 102: Malta – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 103: Malta – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 104: Malta – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 105: Slovakia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 106: Slovakia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 107: Slovakia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 108: Slovakia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 109: Slovenia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 110: Slovenia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 111: Slovenia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 112: Slovenia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 113: Australia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 114: Australia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 115: Australia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 116: Australia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 6 117: New Zealand – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
Figure 6 118: New Zealand – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
Figure 6 119: New Zealand – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
Figure 6 120: New Zealand – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
Figure 7 1: Worldwide – Fluarix / Flulaval Seasonal Influenza Vaccine Sales (Million US$), 2007 – 2013
Figure 7 2: Worldwide – Forecast for Fluarix / Flulaval Seasonal Influenza Vaccine Sales (Million US$), 2014 – 2019
Figure 7 3: Worldwide – Afluria/Fluvax Seasonal Influenza Vaccine Sales (Million US$), 2010 – 2013
Figure 7 4: Worldwide – Forecast for Afluria/Fluvax Seasonal Influenza Vaccine Sales (Million US$), 2014 – 2019
Figure 7 5: Worldwide – Flumist/ Fluenz Seasonal Infuenza Vaccine Sales (Million US$), 2009 – 2013
Figure 7 6: Worldwide – Forecast for Flumist/Fluenz Seasonal Influenza Vaccine Sales (Million US$), 2014 – 2019
Figure 7 7: Worldwide – Influvac Seasonal Infuenza Vaccine Sales (Million US$), 2007 – 2009
Figure 7 8: Worldwide – Fluvirin/Flucelvax Seasonal Infuenza Vaccine Sales (Million US$), 2010 – 2013
Figure 7 9: Worldwide – Forecast for Fluvirin/Flucelvax Seasonal Infuenza Vaccine Sales (Million US$), 2014 – 2019
Figure 7 10: Worldwide – Fluzone Seasonal Infuenza Vaccine Sales (Million US$), 2009 – 2013
Figure 7 11: Worldwide – Forecast for Fluzone Seasonal Infuenza Vaccine Sales (Million US$), 2014 – 2019
